Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis
Hommes, O.R.; Comi, G.
€ 121.64
FREE Delivery in Ireland
Description for Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis
paperback. Series: Topics in Neuroscience. Num Pages: 199 pages, biography. BIC Classification: MJN; MMPH. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 12. Weight in Grams: 343.
There is now evidence that irreversible brain damage accumulates very early in the course of multiple sclerosis. This book reviews the main neurobiological, magnetic resonance imaging, and clinical aspects of the early phases of the dis ease. Mechanisms ofirreversible axonal damage and the role played by the inter action of glia and the axon are highlighted. In contrast to what was believed for a long time, the sufficient availability of oligodendrocyte precursor cells to promote remyelination in acute lesions has now been demonstrated. For reasons not understood, this remyelination process fails or does not start, particularly in the chronic stages ... Read more
There is now evidence that irreversible brain damage accumulates very early in the course of multiple sclerosis. This book reviews the main neurobiological, magnetic resonance imaging, and clinical aspects of the early phases of the dis ease. Mechanisms ofirreversible axonal damage and the role played by the inter action of glia and the axon are highlighted. In contrast to what was believed for a long time, the sufficient availability of oligodendrocyte precursor cells to promote remyelination in acute lesions has now been demonstrated. For reasons not understood, this remyelination process fails or does not start, particularly in the chronic stages ... Read more
Product Details
Format
Paperback
Publication date
2012
Publisher
Springer Italy
Number of pages
199
Condition
New
Series
Topics in Neuroscience
Number of Pages
199
Place of Publication
Milan, Italy
ISBN
9788847021716
SKU
V9788847021716
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
Reviews for Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis